Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2002
09/17/2002US6451540 2′-O-alkylthioalkyl and 2′-C-alkythioalkyl containing nucleic acids
09/17/2002US6451536 Products for detecting nucleic acids
09/17/2002US6451531 Dioxetane labeled probes and detection assays employing the same
09/17/2002US6451225 Mixtures of chelate compounds, amines and electrolytes used for chemical and quantitative analysis; detection of electromagnetic radiations emitted; accuracy
09/17/2002CA2402822A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
09/17/2002CA2278878C Very large scale immobilized peptide synthesis
09/17/2002CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof
09/17/2002CA2187908C Non-splicing variants of gp350/220
09/17/2002CA2145405C Nucleotides labelled with an infrared dye and their use in nucleic acid detection
09/17/2002CA2131543C Comparative genomic hybridization
09/12/2002WO2002070750A2 Method of determining dihydropyrimidine dehydrogenase gene expression
09/12/2002WO2002070738A2 Diagnosis and treatment of blood disorders
09/12/2002WO2002070722A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
09/12/2002WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
09/12/2002WO2002070689A1 Method of extracting virus gene and extraction apparatus
09/12/2002WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor
09/12/2002WO2002057409A3 Antisense modulation of src-2 expression
09/12/2002WO2002042771A3 Detection of binding reactions using catalytic electrochemical labels
09/12/2002WO2001016372A9 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor
09/12/2002WO2000053616A3 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
09/12/2002US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases
09/12/2002US20020128466 Method of synthesizing phosphorothioate oligonucleotides
09/12/2002US20020128381 Polysaccharide having an aminated keto-carboxy group e.g. derived from KDO (2-keto-3-deoxy-D-manno-octonic acid))
09/12/2002US20020128224 Administering a nucleoside 5'-pyrophosphate pyranoside or analogue, of given formula
09/12/2002US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state
09/12/2002US20020128217 Therapeutic use of cis-element decoys in vivo
09/12/2002US20020127713 Specific tolerance in transplantation
09/12/2002US20020127691 Enzymatic protein for treating inflammation, thrombosis andrestenosis
09/12/2002US20020127684 Novel cark protein and nucleic acid molecules and uses therefor
09/12/2002US20020127663 Nucleotide sequences coding enzymatic polypeptide for use in human generation of amino acids for use in human therapeutics and animal nutrients
09/12/2002US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics
09/12/2002US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors
09/12/2002US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor
09/12/2002US20020127599 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
09/12/2002US20020127595 Endostatin; for use as a contraceptive and in cancer treatment
09/12/2002US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/12/2002US20020127578 Compositions and methods relating to prostate specific genes and proteins
09/12/2002US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders
09/12/2002US20020127574 Detecting genetically engineered nucleotide sequences; obtain nucleotide sequences, join to nanoparticles, incubate with probe, monitor adjustment in nucleotide sequence activity
09/12/2002US20020127571 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
09/12/2002US20020127552 Replica amplification of nucleic acid arrays
09/12/2002US20020127550 Nucleic acid sequences and methods for identifying compounds that affect rna/rna binding protein interactions and mrna functionality
09/12/2002US20020125214 Silver stain removal by chemical etching and sonication
09/12/2002CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
09/12/2002CA2439042A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts
09/11/2002EP1238116A1 Process for labeling a nucleic acid
09/11/2002EP1238109A2 Methods and kits for discovery of rna-binding antimicrobials
09/11/2002EP1237909A2 Human g protein-coupled receptors
09/11/2002EP1237900A1 Subunit optimized fusion proteins
09/11/2002EP1237899A2 Nucleic acid compounds and screening assays using the same
09/11/2002EP0808169A4 Programmed cell death genes and proteins
09/11/2002CN1368511A Human protein with cancer inhibiting function and its coding sequence
09/11/2002CN1368510A Human protein with suppression to cancer cell growth and its coding sequence
09/11/2002CN1368509A Human protein with suppression to cancer cell growth and its coding sequence
09/11/2002CN1368508A Human protein with cancer inhibiting function and its coding sequence
09/11/2002CN1368505A Material and process for extracting and purifying DNA, RNA and protein
09/11/2002CN1368504A DNA sequence of dendrobium and method for discriminating its veriety and judging if it is true or false
09/10/2002US6448407 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
09/10/2002US6448381 DNA encoding heparin-binding growth factor
09/10/2002US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease
09/10/2002US6448091 Bindin assay that measures the presence of an analyte of interest by measuring luminescence emitted by one or more labeled components of the assay
09/10/2002US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent
09/10/2002US6448065 Integrated sequencing device
09/10/2002US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis
09/10/2002US6448036 ribB
09/10/2002US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer
09/10/2002US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes.
09/10/2002US6448008 Fluorescent cyanine labels containing a sulfamido linker arm
09/10/2002US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of
09/10/2002US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed.
09/10/2002US6447764 Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles
09/10/2002CA2073441C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene
09/06/2002WO2002069369A2 Cpg-like nucleic acids and methods of use thereof
09/06/2002WO2002068694A1 Differentially methylated sequences in pancreatic cancer
09/06/2002WO2002068692A1 Methods for improving or altering promoter/enhancer properties
09/06/2002WO2002068674A2 Non-enzymatic large scale synthesis of rna
09/06/2002WO2002068665A2 Constitutive promoter from arabidopsis
09/06/2002WO2002068628A1 70 human secreted proteins
09/06/2002WO2002068582A2 Phosphorothioate (p=s) oligonucleotides containing modified nucleotides with six-membered azasugars and use for aids therapy thereof
09/06/2002WO2002068537A2 Fluorescent dye
09/06/2002WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
09/06/2002WO2002038728A3 Method for removing a universal linker from an oligonucleotide
09/06/2002WO2002031482A3 Device and method for electrically accelerated immobilisation of molecules
09/06/2002WO2002020842A8 System, method and apparatus for transgenic and targeted mutagenesis screening
09/06/2002WO2002020537A3 Linker phosphoramidites for oligonucleotide synthesis
09/06/2002WO2001049687A9 Cyclohexene nucleic acids
09/06/2002WO2001048247A3 METHOD FOR GENERATION OF LONGER cDNA FRAGMENTS FROM SAGE TAGS FOR GENE IDENTIFICATION
09/06/2002WO2001018524A9 Methods for improving signal detection from an array
09/06/2002CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof
09/06/2002CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis
09/06/2002CA2433474A1 70 human secreted proteins
09/05/2002US20020123611 Membrane polypeptides for use in treatment of kidney defects
09/05/2002US20020123463 As diagnostics, biosensors and bioreactors, pharmaceuticals
09/05/2002US20020123458 Endostatin protein and fragments thereof
09/05/2002US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals
09/05/2002US20020123060 Detection of non-viral organisms with SRP RNA
09/05/2002US20020123053 Methods for isolating centromere DNA
09/05/2002US20020123051 Tumor therapy; obtain tissue, incubate with antitumor agents, fix tissue, isolate nucleotide sequences, amplify and monitor gene expreesion in sample
09/05/2002US20020123032 Detection of disease related genes
09/04/2002EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof